KYTHERA Biopharmaceuticals Articles

Significant and sustainable reduction in "double chin" with Bayer's ATX-101

4 April 2013

Positive results for KYTHERA and Bayer's ATX-101 in the reduction of "double chin"

4 March 2013

KYTHERA Biopharma gets $33.3 million in payments from Bayer

7 June 2012

Showing 1-3 of 3 articles

Go to beginningPrevious
  • 1
NextGo to end